INTERNATIONAL ISOTOPES INC
10-Q, EX-27.1, 2000-11-20
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: INTERNATIONAL ISOTOPES INC, 10-Q, 2000-11-20
Next: PRICE T ROWE TAX EFFICIENT BALANCED FUND INC, 497, 2000-11-20



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                       2,619,778
<SECURITIES>                                         0
<RECEIVABLES>                                1,934,137
<ALLOWANCES>                                         0
<INVENTORY>                                  3,739,779
<CURRENT-ASSETS>                               934,393
<PP&E>                                      45,926,939
<DEPRECIATION>                             (4,079,994)
<TOTAL-ASSETS>                              54,240,961
<CURRENT-LIABILITIES>                        9,272,567
<BONDS>                                              0
                       17,397,537
                                          0
<COMMON>                                        97,422
<OTHER-SE>                                  11,452,529
<TOTAL-LIABILITY-AND-EQUITY>                54,240,961
<SALES>                                      4,924,879
<TOTAL-REVENUES>                             4,924,879
<CGS>                                        8,567,962
<TOTAL-COSTS>                                9,483,461
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                           1,473,722
<INCOME-PRETAX>                           (14,486,736)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                       (14,486,736)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                              (14,486,736)
<EPS-BASIC>                                     (2.90)
<EPS-DILUTED>                                   (2.90)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission